Olivier Michielin discusses abstracts presented at ESMO Congress 2022:
2022
Awakening ‘dormant’ cells to fight cancer
The advent of small-molecule targeted therapies, a decade ago, revolutionized the treatment of metastatic melanoma, provided that the tumors carry the mutations to respond to these treatments.
Frequency and Risk Factors for Melanoma and Non-Melanoma Skin Cancer
The 1-year frequency of melanoma and nonmelanoma skin cancers (NMSC) in Turkey has been estimated and some of the risk factors in the development of skin cancer have been identified, according to study findings published in the Journal of Cosmetic Dermatology.
Diet patterns linked to success in immunotherapy for melanoma, research finds
Experts have found evidence that diet could make a crucial difference to someone’s ability to fight melanoma.